PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
112 hedge funds and large institutions have $133M invested in Provention Bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $143M → $133M (-$10M)
Holders
112
Holding in Top 10
–
Calls
$4.5M
Puts
$1.63M
Top Buyers
| 1 | +$9.56M | |
| 2 | +$4.37M | |
| 3 | +$572K | |
| 4 |
DCM
DG Capital Management
New York
|
+$424K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$353K |
Top Sellers
| 1 | -$1.33M | |
| 2 | -$1.27M | |
| 3 | -$1.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$916K |
| 5 |
SG Americas Securities
New York
|
-$840K |